DE60124373D1 - Verwendung von enoxaparin zur behandlung der zerebralen ischämie - Google Patents

Verwendung von enoxaparin zur behandlung der zerebralen ischämie

Info

Publication number
DE60124373D1
DE60124373D1 DE60124373T DE60124373T DE60124373D1 DE 60124373 D1 DE60124373 D1 DE 60124373D1 DE 60124373 T DE60124373 T DE 60124373T DE 60124373 T DE60124373 T DE 60124373T DE 60124373 D1 DE60124373 D1 DE 60124373D1
Authority
DE
Germany
Prior art keywords
enoxaparin
treatment
cerebral ischemia
ischemia
cerebral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60124373T
Other languages
English (en)
Other versions
DE60124373T2 (de
Inventor
Veronique Mary
Jean-Marie Stutzmann
Andre Uzan
Florence Wahl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Application granted granted Critical
Publication of DE60124373D1 publication Critical patent/DE60124373D1/de
Publication of DE60124373T2 publication Critical patent/DE60124373T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60124373T 2000-01-06 2001-01-03 Verwendung von enoxaparin zur behandlung der zerebralen ischämie Expired - Fee Related DE60124373T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0000137 2000-01-06
FR0000137A FR2803522B1 (fr) 2000-01-06 2000-01-06 Nouvelle application therapeutique de l'enoxaparine
PCT/FR2001/000014 WO2001049298A2 (fr) 2000-01-06 2001-01-03 Nouvelle application therapeutique de l"enoxaparine

Publications (2)

Publication Number Publication Date
DE60124373D1 true DE60124373D1 (de) 2006-12-21
DE60124373T2 DE60124373T2 (de) 2007-08-30

Family

ID=8845669

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60124373T Expired - Fee Related DE60124373T2 (de) 2000-01-06 2001-01-03 Verwendung von enoxaparin zur behandlung der zerebralen ischämie

Country Status (30)

Country Link
EP (1) EP1248638B1 (de)
JP (1) JP2003519185A (de)
KR (1) KR20020069240A (de)
CN (1) CN1400905A (de)
AR (1) AR026804A1 (de)
AT (1) ATE344671T1 (de)
AU (1) AU784656B2 (de)
BR (1) BR0107442A (de)
CA (1) CA2396178A1 (de)
CZ (1) CZ20022303A3 (de)
DE (1) DE60124373T2 (de)
DK (1) DK1248638T3 (de)
EA (1) EA006035B1 (de)
EE (1) EE200200374A (de)
ES (1) ES2275648T3 (de)
FR (1) FR2803522B1 (de)
HK (1) HK1052649A1 (de)
HR (1) HRP20020573A2 (de)
HU (1) HUP0204040A3 (de)
IL (1) IL150477A0 (de)
MX (1) MXPA02006672A (de)
NO (1) NO20023243D0 (de)
NZ (1) NZ520283A (de)
PL (1) PL357192A1 (de)
PT (1) PT1248638E (de)
SK (1) SK9612002A3 (de)
UA (1) UA75587C2 (de)
WO (1) WO2001049298A2 (de)
YU (1) YU51802A (de)
ZA (1) ZA200205415B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR063530A1 (es) * 2006-10-30 2009-01-28 Aventis Pharma Sa Procedimiento de utilizacion de enoxaparina sodica para la preparacion de un medicamento
ITMI20091445A1 (it) * 2009-08-07 2011-02-08 Inalco S P A A Socio Unico Derivati semi-sintetici del polisaccaride k5 per la prevenzione ed il trattamento del danno tissutale associato a ischemia e/o riperfusione

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994008595A1 (en) * 1992-10-13 1994-04-28 Virginia Commonwealth University Use of non-anticoagulant heparin for treating ischemia/reperfusion injury
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics

Also Published As

Publication number Publication date
UA75587C2 (en) 2006-05-15
PL357192A1 (en) 2004-07-26
EP1248638B1 (de) 2006-11-08
HUP0204040A2 (hu) 2003-04-28
EP1248638A2 (de) 2002-10-16
HRP20020573A2 (en) 2003-10-31
FR2803522A1 (fr) 2001-07-13
MXPA02006672A (es) 2002-09-30
YU51802A (sh) 2005-06-10
AR026804A1 (es) 2003-02-26
IL150477A0 (en) 2002-12-01
CN1400905A (zh) 2003-03-05
EA200200750A1 (ru) 2003-02-27
WO2001049298A3 (fr) 2002-04-04
NZ520283A (en) 2004-09-24
AU784656B2 (en) 2006-05-18
DK1248638T3 (da) 2007-03-19
BR0107442A (pt) 2002-10-08
JP2003519185A (ja) 2003-06-17
EA006035B1 (ru) 2005-08-25
NO20023243L (no) 2002-07-04
DE60124373T2 (de) 2007-08-30
CA2396178A1 (fr) 2001-07-12
SK9612002A3 (en) 2002-12-03
FR2803522B1 (fr) 2004-01-02
HUP0204040A3 (en) 2003-05-28
EE200200374A (et) 2003-12-15
PT1248638E (pt) 2007-02-28
WO2001049298A2 (fr) 2001-07-12
AU3183001A (en) 2001-07-16
HK1052649A1 (zh) 2003-09-26
KR20020069240A (ko) 2002-08-29
ES2275648T3 (es) 2007-06-16
CZ20022303A3 (cs) 2002-11-13
ATE344671T1 (de) 2006-11-15
ZA200205415B (en) 2003-10-13
NO20023243D0 (no) 2002-07-04

Similar Documents

Publication Publication Date Title
ATE275145T1 (de) Chinazolinderivate zur behandlung von tumoren
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60114580D1 (de) Verwendung von cyanochinolinen zur behandlung oder inhibierung von dickdarmpolypen
DE60325770D1 (de) Verwendung von rimexolon zur behandlung von augentrockenheit
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
DE69941566D1 (de) N-acetylhomotaurinate zur verwendung in der behandlung von hyperkinesie
DE60113496D1 (de) Verwendung von Glycyrrhizin zur Behandlung von Mastitis.
EE200200172A (et) Ühendid isheemia ravimiseks
ATE417602T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
ATE410430T1 (de) 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose
DE60011570D1 (de) Arylpiperazinyl-cyclohexyl indolderivate zur behandlung von depressionen
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
DE60136477D1 (de) Retinoide zur behandlung von emphysem
DE502004010131D1 (de) Pyridopyrimidinone zur behandlung von krebserkrankungen
DE60030554T8 (de) Verwendungen von et743 zur behandlung von krebs
DE60220043D1 (de) Carbamatverbindungen zur vorbeugung oder behandlung von neurodegenerativen störungen
ATE254913T1 (de) Diacerein zur behandlung von psoriasis
DE602005016141D1 (de) S-mirtazapin zur behandlung von hitzewallungen
ATE504297T1 (de) Visnadin zur behandlung von kopfhautjucken
DE60238765D1 (de) Carbamatverbindungen zur behandlung von schmerz
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
DE60214355D1 (de) Exemestan zur behandlung von hormonabhängigen störungen
ATE273276T1 (de) Cyclobutendion-derivate zur behandlung von artherosclerose
ATE482707T1 (de) 1-ä2h-1-benzopyran-2-on-8-ylü- piperazin- derivate zur behandlung von schmerzen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee